What's behind Hims & Hers Health's latest 4.2% stock pullback?

What's behind Hims & Hers Health's latest 4.2% stock pullback?
Hims & hers health drops 4.23% today

Hims & Hers Health Inc (HIMS) dropped 4.23% amid ongoing technical pressure, with a lack of recent company news shaping sentiment. The decline is reinforced by the stock trading below its key moving averages and heavy selling momentum across all timeframes.

HIMS price prediction
24H 0.11%
$18.58
48H -0.16%
$18.53
7D -1.72%
$18.24
1M -36.21%
$11.84
3M -52.05%
$8.9
6M -71.5%
$5.29
12M -57.92%
$7.81
Current price: $18.56 -1.1800 5.98%
Closed 11/16
Daily range 18.46 Arrow from to Icon 19.14
Weekly range 18.42 Arrow from to Icon 22.12
Loading...

Highlights

  • Shares of Hims & Hers Health trade below key short-, medium-, and long-term averages, indicating seller pressure across all timeframes.
  • Momentum indicators confirm a bearish trend, with MACD, ADX, negative Bull/Bear Power, and the Awesome Oscillator all showing sell signals.
  • The price is forecast to move between $17.05 and $20.75 over the next five days, with a 78% probability of decline and $18.42 as crucial support.
Anton Kharitonov, expert at Traders Union, notes that Hims & Hers Health Inc remains vulnerable as selling intensifies. He sees persistent lack of positive drivers, with no fresh company news to spark investor optimism. Technically, the stock trades consistently below all major moving averages, with strong bearish alignment across indicators like MACD and ADX. Oversold oscillators may suggest some selling exhaustion, but the overall risk for more downside is significant. "Until momentum or solid fundamentals change, the odds favor continued pressure and traders should avoid premature entries here."
Viktoras Karapetjanc, expert at Traders Union, believes the current consolidation in Hims & Hers Health offers attractive setups for forward-looking investors. He highlights that increased volatility creates opportunity near these support and resistance zones. Stronger buyers could step in if price breaks above $19.20, opening the path for a broader recovery. "I see plenty of setups for those watching closely — persistent structure can still underpin further growth despite short-term setbacks."
Parshwa Turakhiya, analyst, sees sentiment around Hims & Hers Health as fragile due to ongoing selling and no positive news catalyst. He points out heightened volatility and oversold signals, suggesting the potential for quick intraday reversals. Turakhiya cautions that traders should watch for a sharp move if either $19.20 or $18.42 is breached. "With sentiment on edge, nimble traders should be ready for rapid swings in either direction this week."
Hims & Hers Health Inc. asset chart
Hims & Hers Health Inc. price dynamics. Source: TradingView.

Bearish signals intensify with persistent oversold momentum

Hims & Hers Health is trading below its short-, medium-, and long-term moving averages, with the current price at $18.90 compared to the MA-20 at $25.78, MA-50 at $27.61, and MA-200 at $26.68. This structure signals continued pressure from sellers, even as the MA-50 remains above the MA-200. Technical indicators are mostly bearish: MACD and ADX show sell signals, Bull/Bear Power and the Awesome Oscillator are negative, and intraday volatility is high at 4.90%. The RSI sits in a neutral range, while both Stochastic RSI and CCI are in oversold territory, hinting at possible selling exhaustion. The nearest resistance is at $19.20, with support at $18.42.

In a recent review, analysts highlighted persistent downside risk and bearish technical momentum for Hims & Hers Health shares. The latest price action reinforces this negative bias, making the $18.42 support level a key threshold for traders to monitor in the coming sessions.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.